SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 33 filers reported holding SATSUMA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $195,000 | +27.5% | 46,998 | +116.5% | 0.00% | – |
Q2 2021 | $153,000 | -67.2% | 21,707 | -72.5% | 0.00% | – |
Q1 2021 | $467,000 | +8.9% | 79,052 | -15.0% | 0.00% | – |
Q4 2020 | $429,000 | +3200.0% | 92,953 | +2613.2% | 0.00% | – |
Q3 2020 | $13,000 | -97.3% | 3,426 | -79.7% | 0.00% | – |
Q2 2020 | $486,000 | +42.5% | 16,890 | +6.3% | 0.00% | – |
Q1 2020 | $341,000 | +1117.9% | 15,887 | +1001.7% | 0.00% | – |
Q4 2019 | $28,000 | – | 1,442 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 3,118,761 | $14,533,000 | 3.83% |
Ghost Tree Capital, LLC | 904,225 | $4,214,000 | 1.23% |
RA Capital Management | 5,914,252 | $27,560,000 | 0.38% |
Vivo Capital, LLC | 1,232,394 | $5,743,000 | 0.26% |
Nan Fung Group Holdings Ltd | 142,900 | $666,000 | 0.21% |
Ikarian Capital, LLC | 629,384 | $2,934,000 | 0.21% |
NEA Management Company, LLC | 3,142,958 | $14,646,000 | 0.17% |
SAMLYN CAPITAL, LLC | 1,716,067 | $7,998,000 | 0.11% |
TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $8,788,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 90,665 | $422,000 | 0.04% |